key: cord-0867916-nr05tw15 authors: Eterovic, André; Sperança, Márcia Aparecida; de Campos, Ivana Barros; Colpas, Daniela Rodrigues; Rodart, Itatiana Ferreira; Carmo, Andréia Moreira dos Santos; de Mattos, Elaine Cristina; Daros, Vilma dos Santos Menezes Gaiotto; Cergole‐Novella, Maria Cecilia title: SARS‐CoV‐2 intralineage variation and temporal patterns of COVID‐19 risk factors in three cities of southeastern Brazil: Age, sex, and race date: 2022-02-01 journal: J Med Virol DOI: 10.1002/jmv.27607 sha: 6f63a29a38ccba3acc2f27b7008dfca70f8311bb doc_id: 867916 cord_uid: nr05tw15 The Santo André Regional Center from Adolfo Lutz Institute evaluated 91 537 samples by reverse transcription‐polymerase chain reaction (RT‐PCR) to detect severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) from March 2020 to April 2021. The age, sex, and race of patients from three cities in southeastern Brazil, namely São Bernardo do Campo (SBC), Diadema, and Mauá were assessed in association to the rate of positive results using generalized linear models. Circulating lineages were obtained from GISAID and intralineage genetic variation was investigated employing Lasergene software. A declining number of reported cases around October to November 2020 separate two epidemic waves in the three cities. Mauá differed by the highest positive RT‐PCR scores in January and February. GISAID classification of 38 SARS‐CoV‐2 complete genomic sequences showed the circulation of lineages P.1, B.1.1.28, P.2, B.1.1.332; P.1, P.2, B.1.1.28, B.1.1.33; and P.1, P.2 in SBC, Diadema and Mauá, respectively. Intralineage variation revealed a significant amino‐acid substitution in the ORF3a encoding protein (A33S) present in four out of six (67%) P.1 Mauá isolates. As ORF3a encodes a nonselective Ca(2+) permeable cation channel, supposed to interfere in airway homeostasis, specific mutations could increase its pathogenic effect resulting in a higher number of symptomatic individuals explaining why the second wave was more intense in Mauá city. mainly through secretions droplets of the upper respiratory tract. The surveillance of respiratory viruses of public health relevance has a characteristic dynamic, due to their potential to cause epidemics. Studies that result in an improved understanding of COVID-19 may lead to more targeted and effective communitybased and healthcare system-based interventions. The collection of COVID-19 data among specific population strata and their dissemination remains critically important to guide policy, health care, prevention, and intervention efforts. 5, 6 For diagnosis of COVID-19, nasopharyngeal secretion samples are obtained by using synthetic fiber swabs with a plastic rod, being the best time for collection between the first and the seventh day after the onset of symptoms. 7 In hospitalized patients, the Brazilian Ministry of Health recommends the collection of bronchoalveolar lavage, tracheal or nasopharynx suction, or even oropharynx as the preferred swab sample. The collection process of these clinical samples is less prone to errors than those previously indicated swab methods, thus favoring results with greater accuracy for reverse transcriptionpolymerase chain reaction (RT-PCR) in real time. 7 It is possible to detect the presence of viral RNA still in the initial stage of the disease, assisting in the diagnosis for better medical conduct, as well as in the necessary public health interventions. The World Health Organization (WHO) reputes RT-PCR as the gold standard for laboratory diagnosis, being essential in the pandemic context. 8 Discrimination of SARS-CoV-2 lineages is associated with important epidemiological and biological events and the detection of changes in amino acid sequences along virus encoding proteins are based on comparison to the first isolate from the Chinese Hubei province (the root sequence). 9 Assignment of epidemiological lineages in an emerging pandemic is usually done by using the Pangolin tool. 9,10 Camargo et al. 11 report a predominance of B.1.1.33 (30.3%, n = 3028 sequences) and B.1.1.28 (26.6%) strains circulating in Brazil. In Sao Paulo state, Southeastern Brazil, B.1.1.28 was the first-ranked. It was the source for P.1 (the so-called Gama variant) and P.2, both commonly detected in the state, and also for P. 3 , not reported in the country during the study period. B.1.1.28 has been found in 46 countries, P.1 in 27, P.2 in 28, and P.3 has been reported only in the Philippines. 12 The Adolfo Lutz Institute, Santo André Regional Center (IAL Santo André), Sao Paulo, Brazil, as the central public health laboratory, is responsible for laboratory tests of various diseases required for epidemiological surveillance. During the first year of the COVID-19 pandemic, the diagnosis of SARS-CoV-2 was included in a platform used in this study to describe the epidemiological characteristics of symptomatic patients from Sao Paulo state. Our purpose is to evaluate the association of positive RT-PCR results to demographic factors (age, sex, and race/ethnicity) in three cities with massive records (São Bernardo, Diadema, and Mauá), besides the identification of the main circulating virus lineages. individual, aged less than 90 years and affected with a mild respiratory syndrome. Scattered data from indigenous people were also discarded. The three cities were compared according to temporal trends in the rate of positive test results, as assessed in the two waves of the pandemics which strike such regions during the time course of sampling. For practical reasons, these waves were detached by the lowering of the daily incidence rate around the October to November 2020 edge, as detected using external, unofficial data. 13 The probability of a positive test result (response variable) was assessed by generalized linear models with a binomial error distribution, using wave, city, day of collection, age, sex, and race/ethnicity as risk factors (predictors). Models were built to investigate the additive contribution of such variables. Interactions were also assessed by partitioning the data set by wave, city, and combinations of both. R program was used in such analysis. Nasopharyngeal secretion samples (combined nose and throat) were collected with synthetic fiber swabs (rayon) with a plastic rod between the third and seventh day after the onset of symptoms. In hospitalized patients, was collected bronchoalveolar lavage, tracheal or nasopharynx suction, adopting oropharynx as the preferred swab sample. The RT-PCR reactions for SARS-CoV-2 detection were performed using different methodologies, described below into three protocols. Until July 2020, samples had RNA extracted with silica columns, using Biogene kit (Quibasa) and RT-PCR reactions were performed with SARS-CoV-2 molecular kit (Bio-Manguinhos) for individual gene E detection of SARS-CoV-2 and human RP gene as a positive control, as standardized in Charité laboratory protocol. 14 From August to November 2020, samples were subjected to heat/chemical extraction using QuickExtract DNA Extraction Solution kit (Lucigen), and RT-PCR reactions were performed with IDT primer kit and GoTaq Probe 1-enzyme Step RT-qPCR System (Promega) for individual detection of N1 and N2 genes, according to a protocol standardized by Centers for Disease Control and Prevention (CDC), 15, 16 in addition to detection of the RP gene as a positive control. From December 2020 to April 2021, samples were subjected to automated extraction of genetic material using magnetic microparticles from EXTRACTA kit-DNA and Viral RNA and EXTRACTA 32 equipment (Loccus). RT-PCR reactions were performed with Allplex 2019-nCov Assay kit (Seegene) with modifications for the triplex detection of the E and N genes from SARS-CoV-2, in addition to the human RP gene, whose protocol is also based on the primers designed by Charité laboratory. 14 Part of the tests that were submitted to the IAL Santo André was carried out by other laboratory on the state diagnostic platform, which also adopted similar kits and the protocol of Charité laboratory. All extraction reactions of the genetic material and RT-PCR were performed according to the manufacturers' instructions, as well as the analysis and interpretation of results. The IAL Sao Paulo responds to emerging diseases of public health interest, and it was responsible for sequencing the complete genome of isolated SARS-CoV-2 to monitor the diversity of new coronaviruses. The sequences are deposited and available from the Global Initiative on Sharing All Influenza Data (GISAID). 17 All SARS-CoV-2 lineages described in this study were extracted from GISAID on June 21, 2021. All available SARS-CoV-2 complete sequences from São Bernardo do Campo, Diadema, and Mauá were downloaded and the modified target encoding genes in reference lineages strains were evaluated individually by employing MegAlign of the Lasergene software. 18 After discarding scattered data, the resulting number of records for the remaining cities were São Bernardo do Campo (n = 39 034), Diadema Despite the sequential employment of three different procedures of RNA extraction and RT-PCR along the period of sample scanning, such protocols were not treated as levels of another explaining factor in the analysis of the chance of positive tests. As the third protocol was almost temporally coincident with the second epidemic wave, it should be statistically impossible to isolate its effect (i.e., to detach the contribution of "WAVE" and "PROTOCOL"). So, we assumed that the trend described at the beginning of this paragraph (Figure 1 ), as detected also in the external data ( Figure SA1 ), was entirely attributed to the waves and not to the methodological approach. This same "waving" pattern was recurrent among 15-years age classes, especially those of 30, 45, and 60 years, as labeled by their upper limit ( Figure 2) . It also appears in distinct genders ( Figure 3 ) and races, especially in categories "white," "mixed," and "unreported" (Table 1) . As indicated by their significant coefficients, the next factors in importance were "city" (Diadema and Mauá with a lower and a higher chance, respectively, of a positive result than São Bernardo do Campo) and "sex" (females less prone to positive results than males). Each year in age promotes an increase of 1.6% in the odds of a positive outcome. Each day after July 1, 2020, represents an increase of less than 0.1% in the odds of a positive outcome but such effect did not resist an adjusted critical P. No race category differed from the reference level ("white") except the "unreported," which presented a significant, increased odds of positive results. The models using data subset by wave (Table 2) Cutting the data by city (Table 3) Table SA1 . Accession number of obtained sequences are described in Table A1, As pointed before, Mauá differed from the other two neighbor cities by higher positive RT-PCR scores in January and February 2021, mainly in age classes 30, 45, and 60, in both genders, in all race categories except "black," and presented at least two different variants, P.1 and P.2. It is important to note that, so far, there is no evidence that the variant P.1 is more virulent or transmissible compared to other previously identified. P.1 strain has been found in 27 countries and in Brazil, and it had an increased incidence in the period of this study. 11, 21 Since the first identification of SARS-CoV-2 to date, more than 414 575 complete genomic sequences worldwide are available through public access databases. The ability to monitor viral evolution in near real-time has a direct impact on the public health response to the COVID-19 pandemic. 22 Camargo et al. 11 reported that in just over a year after the COVID-19 pandemic was decreed, Brazil deposited 4606 sequences on GISAID, being the IAL Sao Paulo The response variable is the probability of a positive outcome. The first wave lasts from July to October 2020 and the second, from November 2020 to April 2021. They were defined by lower values of reported cases in external data. 13 "São Bernardo do Campo" is the reference level for cities, as well as "male" for sex and "white" for the race. Days of collection starting at July 1, 2020; age measured in years. Logistic regression coefficients (B) are shown with respective standard errors (SE), odds ratios (OR), and 95% confidence limits (CI). *p < 0.05; **p < 0.0167 (= 0.05/3) for City, p < 0.0125 (= 0.05/4) for Wave and p < 0.0042 (=0.05/12) for the remainder; after a Bonferronicorrection for the number of times a given factor was included in an analysis(a given model) in the whole paper. Note: The response variable is the probability of a positive outcome. The first wave lasts from July to October 2020 and the second, from November 2020 to April 2021. They were defined by lower values of reported cases in external data. 13 "Male" is the reference level for sex and "white" for the race. Days of collection starting at July 1, 2020; age measured in years. Logistic regression coefficients (B) are shown with respective standard errors (SE), odds ratios (OR), and 95% confidence limits (CI). *p < 0.05; **p < 0.0167 (= 0.05/3) for City, *p < 0.0125 (= 0.05/4) for Wave and p < 0.0042 (=0.05/12) for the remainder; after a Bonferroni correction for the number of times a given factor was included in an analysis (a given model) in the whole paper. Note: The response variable is the probability of a positive outcome. The first wave lasts from July to October 2020 and the second, from November 2020 to April 2021. They were defined by lower values of reported cases in external data. 13 "Male" is the reference level for sex and "white" for the race. Days of collection starting at July 1, 2020; age measured in years. Logistic regression coefficients (B) are shown with respective standard errors (SE), odds ratios (OR), and 95% confidence limits (CI). p < 0.05; **p < 0.0167 (= 0.05/3) for City, p< 0.0125 (= 0.05/4) for Wave and p < 0.0042 (=0.05/12) for the remainder; after a Bonferroni correction for the number of times a given factor was included in an analysis (a given model) in the whole paper. A novel coronavirus from patients with pneumonia in China WHO. Novel Coronavirus (2019-nCoV) Situation Report-1;2020a:5 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 United States COVID-19 and racial/ ethnic disparities Emergência de Saúde Pública de Importância Nacional pela Doença pelo Coronavírus 2020. Vigilância de Síndromes Respiratórias Agudas-COVID-19. Brasília: Ministério da Saúde World Health Organization (WHO) Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool Latest epidemiological lineages of SARS-CoV-2 A year of the COVID-19 pandemic: genetic diversity of SARS-COV-2 in Brazil A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Boletins epidemiológicos da COVID-19 por município por dia Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Division of Viral Diseases. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel Division of Viral Diseases. 2019-Novel Coronavirus (2019-nCoV) Real-time rRT-PCR Panel Primers and Probes DNASTAR's Lasergene sequence analysis software Instituto Brasileiro de Geografia e Estatística (IBGE) Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil. One Health Welcomed operation: Adolfo Lutz Institute confirms cases of the new variant P.1 of SARSCoV-2 in soldiers of the Welcomed Operation in Roraima Occurrence of Variants of SARS-CoV-2 in the Americas. PAHO/WHO; 2021 Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis. mBio Protocolo laboratorial para coleta, acondicionamento e transporte de amostras biológicas para investigação de SG por SARS-CoV-2. IAL SARS-CoV-2 intralineage variation and temporal patterns of COVID-19 risk factors in three cities of southeastern Brazil: Age, sex, and race The authors declare no conflict of interest. Not applicable. No human sample was collected for the purpose of this study; they were collected for the diagnostic routine of the laboratory.Private information from patients was omitted and data was assessed in a retrospective, aggregated mode, disabling personal identification. The data sets used and analyzed during the current study are available from the corresponding author on reasonable request.